Common use of Labour and Employee Matters Clause in Contracts

Labour and Employee Matters. (a) Schedule 3.1(38) identifies each retirement, pension, bonus, stock purchase, profit sharing, stock option, deferred compensation, severance or termination pay, insurance, medical, hospital, dental, vision care, drug, sick leave, disability, salary continuation, legal benefits, unemployment benefits, vacation, incentive or other compensation plan or arrangement or other employee benefit plan that is maintained or otherwise contributed to, or required to be contributed to, by Tribute Pharma or Tribute Pharmaceuticals for the benefit of employees or former employees of Tribute Pharma or Tribute Pharmaceuticals (the “Employee Plans”) and a true and complete copy of each Employee Plan has been furnished to the Purchaser. Each Employee Plan has been maintained in compliance with its terms and with the material requirements prescribed by any and all Laws that are applicable to such Employee Plan. The Vendors have delivered to the Purchaser the actuarial valuations, if any, prepared for each Employee Plan during the past three years. Except as described in Schedule 3.1(38): (i) all contributions to and payments from each Employee Plan that may have been required to be made in accordance with the terms of any such Employee Plan, or with the recommendation of the actuary for such Employee Plan, and, where applicable, with the Laws that govern such Employee Plan, have been made in a timely manner; (ii) all material reports, returns and similar documents (including applications for approval of contributions) with respect to any Employee Plan required to be filed with any Regulatory Authority or distributed to any Employee Plan participant have been duly filed on a timely basis or distributed; (iii) there are no pending investigations by any Regulatory Authority involving or relating to an Employee Plan, threatened or pending claims (except for claims for benefits payable in the normal operation of the Employee Plans), suits or proceedings against Tribute Pharma or Tribute Pharmaceuticals in respect of any Employee Plan or assertions of any rights or claims to benefits under any Employee Plan that could give rise to a liability nor are there any facts that could give rise to any liability in the event of such investigation, claim, suit or proceeding; (iv) no notice has been received by Tribute Pharma or Tribute Pharmaceuticals of any complaints or other proceedings of any kind involving Tribute Pharma or Tribute Pharmaceuticals or any of the employees of Tribute Pharma or Tribute Pharmaceuticals before any pension board or committee relating to any Employee Plan or to Tribute Pharma or Tribute Pharmaceuticals; and (v) the assets of each Employee Plan are at least equal to the liabilities of such Employee Plans based on the actuarial assumptions utilized in the most recent valuation performed by the actuary for such Employee Plan, and neither the Purchaser nor any of its associates or affiliates (other than Tribute Pharma and Tribute Pharmaceuticals) will incur any liability with respect to any Employee Plan as a result of the Transactions. (b) Except as described in Schedule 3.1(38), neither of Tribute Pharma or Tribute Pharmaceuticals has made any Contract with any labour union or employee association nor made commitments to or conducted negotiations with any labour union or employee association with respect to any future agreements and, except as set out in Schedule 3.1(38), there are no current attempts to organize or establish any labour union or employee association with respect to any employees of Tribute Pharma or Tribute Pharmaceuticals, nor is there any certification of any such union with regard to a bargaining unit. There are no grievances against Tribute Pharma or Tribute Pharmaceuticals for which Tribute Pharma or Tribute Pharmaceuticals has received written notice under any collective agreement. (c) Schedule 3.1(38) contains a complete and accurate list of the names of all individuals who are employees or consultants of Tribute Pharma or Tribute Pharmaceuticals specifying the length of service, title, rate of salary and commission or bonus structure for each such employee. No notice has been received by Tribute Pharma or Tribute Pharmaceuticals of any complaint filed by any of the employees against Tribute Pharma or Tribute Pharmaceuticals claiming that Tribute Pharma or Tribute Pharmaceuticals has violated any Laws applicable to employee or human rights, or of any complaints or proceedings of any kind involving Tribute Pharma or Tribute Pharmaceuticals or any of the employees of Tribute Pharma or Tribute Pharmaceuticals before any labour relations board, except as disclosed in Schedule 3.1(38). All levies, assessments and penalties made against Tribute Pharma or Tribute Pharmaceuticals pursuant to any Laws applicable to workers’ compensation have been paid by Tribute Pharma or Tribute Pharmaceuticals and neither of Tribute Pharma or Tribute Pharmaceuticals has been assessed under any such legislation during the past two years. (d) All accruals for unpaid vacation pay, premiums for employment insurance, health premiums, Canada Pension Plan premiums, accrued wages, salaries and commissions and employee benefit plan payments have been reflected in the Records.

Labour and Employee Matters. (a) Schedule 3.1(383.2(40) identifies each retirement, pension, bonus, stock purchase, profit sharing, stock option, deferred compensation, severance or termination pay, insurance, medical, hospital, dental, vision care, drug, sick leave, disability, salary continuation, legal benefits, unemployment benefits, vacation, incentive or other compensation plan or arrangement or other employee benefit plan that is maintained or otherwise contributed to, or required to be contributed to, by Tribute Pharma or Tribute Pharmaceuticals the Purchaser for the benefit of employees or former employees of Tribute Pharma or Tribute Pharmaceuticals the Purchaser (the “Purchaser Employee Plans”) and a true and complete copy of each Purchaser Employee Plan has been furnished made available to the PurchaserVendors. Each Purchaser Employee Plan has been maintained in compliance with its terms and with the material requirements prescribed by any and all Laws that are applicable to such Purchaser Employee Plan. The Vendors have delivered Purchaser has made available to the Purchaser Vendors the actuarial valuations, if any, prepared for each Purchaser Employee Plan during the past three years. Except as described in Schedule 3.1(383.2(40): (i) all contributions to and payments from each Purchaser Employee Plan that may have been required to be made in accordance with the terms of any such Purchaser Employee Plan, or with the recommendation of the actuary for such Purchaser Employee Plan, and, where applicable, with the Laws that govern such Purchaser Employee Plan, have been made in a timely manner; (ii) all material reports, returns and similar documents (including applications for approval of contributions) with respect to any Purchaser Employee Plan required to be filed with any Regulatory Authority or distributed to any Purchaser Employee Plan participant have been duly filed on a timely basis or distributed; (iii) there are no pending investigations by any Regulatory Authority involving or relating to an Purchaser Employee Plan, threatened or pending claims (except for claims for benefits payable in the normal operation of the Purchaser Employee Plans), suits or proceedings against Tribute Pharma or Tribute Pharmaceuticals the Purchaser in respect of any Purchaser Employee Plan or assertions of any rights or claims to benefits under any Purchaser Employee Plan that could give rise to a liability nor are there any facts that could give rise to any liability in the event of such investigation, claim, suit or proceeding; (iv) no notice has been received by Tribute Pharma or Tribute Pharmaceuticals the Purchaser of any complaints or other proceedings of any kind involving Tribute Pharma or Tribute Pharmaceuticals the Purchaser or any of the employees of Tribute Pharma or Tribute Pharmaceuticals the Purchaser before any pension board or committee relating to any Purchaser Employee Plan or to Tribute Pharma or Tribute Pharmaceuticalsthe Purchaser; and (v) the assets of each Purchaser Employee Plan are at least equal to the liabilities of such Purchaser Employee Plans based on the actuarial assumptions utilized in the most recent valuation performed by the actuary for such Purchaser Employee Plan, and neither the Purchaser nor any of its associates or affiliates (other than Tribute Pharma and Tribute Pharmaceuticals) will incur any liability with respect to any Employee Plan as a result of the Transactions. (b) Except as described in Schedule 3.1(383.2(40), neither of Tribute Pharma or Tribute Pharmaceuticals the Purchaser has not made any Contract with any labour union or employee association nor made commitments to or conducted negotiations with any labour union or employee association with respect to any future agreements and, except as set out in Schedule 3.1(383.2(40), there are no current attempts to organize or establish any labour union or employee association with respect to any employees of Tribute Pharma or Tribute Pharmaceuticalsthe Purchaser, nor is there any certification of any such union with regard to a bargaining unit. There are no grievances against Tribute Pharma or Tribute Pharmaceuticals the Purchaser for which Tribute Pharma or Tribute Pharmaceuticals the Purchaser has received written notice under any collective agreement. (c) Schedule 3.1(383.2(40) contains a complete and accurate list of the names of all individuals who are employees or consultants of Tribute Pharma or Tribute Pharmaceuticals the Purchaser specifying the length of service, age, title, rate of salary and commission or bonus structure for each such employee. No notice has been received by Tribute Pharma or Tribute Pharmaceuticals the Purchaser of any complaint filed by any of the employees against Tribute Pharma or Tribute Pharmaceuticals the Purchaser claiming that Tribute Pharma or Tribute Pharmaceuticals the Purchaser has violated any Laws applicable to employee or human rights, or of any complaints or proceedings of any kind involving Tribute Pharma or Tribute Pharmaceuticals the Purchaser or any of the employees of Tribute Pharma or Tribute Pharmaceuticals the Purchaser before any labour relations board, except as disclosed in Schedule 3.1(383.2(40). All levies, assessments and penalties made against Tribute Pharma or Tribute Pharmaceuticals the Purchaser pursuant to any Laws applicable to workers’ compensation have been paid by Tribute Pharma or Tribute Pharmaceuticals the Purchaser and neither of Tribute Pharma or Tribute Pharmaceuticals the Purchaser has not been assessed under any such legislation during the past two years. (d) All accruals for unpaid vacation pay, premiums for employment insurance, health premiums, Canada Pension Plan premiums, accrued wages, salaries and commissions and employee benefit plan payments have been reflected in the Records.

Labour and Employee Matters. (a) Schedule 3.1(383.1(30) identifies each retirement, pension, bonus, stock purchase, profit sharing, stock option, deferred compensation, severance or termination pay, insurance, medical, hospital, dental, vision care, drug, sick leave, disability, salary continuation, legal benefits, unemployment benefits, vacation, incentive or other compensation plan or arrangement or other employee benefit plan that is maintained or otherwise contributed to, or required to be contributed to, by Tribute Pharma the Vendor relating to the Business or Tribute Pharmaceuticals the Purchased Assets for the benefit of employees or former employees of Tribute Pharma or Tribute Pharmaceuticals the Vendor (the “Employee Plans”) and a true and complete copy of each Employee Plan has been furnished to the Purchaser. Each Employee Plan has been maintained in compliance with its terms and with the material requirements prescribed by any and all Laws that are applicable to such Employee Plan. The Vendors have delivered There are no pension plans maintained by the Vendor pertaining to the Purchaser Business for the actuarial valuations, if any, prepared for each Employee Plan during benefit of employees of the past three yearsBusiness. Except as described in Schedule 3.1(383.1(30): (i) all contributions to and payments from each Employee Plan that may have been required to be made in accordance with the terms of any such Employee Plan, or with the recommendation of the actuary for such Employee Plan, Plan and, where applicable, with the Laws that govern such Employee Plan, have been made in a timely manner; (ii) all material reports, returns and similar documents (including applications for approval of contributions) with respect to any Employee Plan required to be filed with any Regulatory Authority or distributed to any Employee Plan participant have been duly filed on a timely basis or distributed; (iii) there are no pending investigations by any Regulatory Authority involving or relating to an Employee Plan, threatened or pending claims (except for claims for benefits payable in the normal operation of the Employee Plans), suits or proceedings against Tribute Pharma or Tribute Pharmaceuticals the Vendor in respect of any Employee Plan or assertions of any rights or claims to benefits under any Employee Plan that could give rise to a liability nor are there any facts that could give rise to any liability in the event of such investigation, claim, suit or proceeding;; and (iv) no notice has been received by Tribute Pharma or Tribute Pharmaceuticals the Vendor of any complaints or other proceedings of any kind involving Tribute Pharma or Tribute Pharmaceuticals the Vendor or any of the employees of Tribute Pharma or Tribute Pharmaceuticals the Vendor before any pension board or committee relating to any Employee Plan or to Tribute Pharma or Tribute Pharmaceuticals; and (v) the assets of each Employee Plan are at least equal to the liabilities of such Employee Plans based on the actuarial assumptions utilized in the most recent valuation performed by the actuary for such Employee Plan, and neither the Purchaser nor any of its associates or affiliates (other than Tribute Pharma and Tribute Pharmaceuticals) will incur any liability with respect to any Employee Plan as a result of the TransactionsVendor. (b) Except as described in Schedule 3.1(38), neither of Tribute Pharma or Tribute Pharmaceuticals The Vendor has not made any Contract pertaining to the Business with any labour union or employee association nor made commitments to or conducted negotiations with any labour union or employee association with respect to any future agreements and, except as set out in Schedule 3.1(38)to the best knowledge of the Vendor, there are no current attempts to organize or establish any labour union or employee association with respect to any employees of Tribute Pharma or Tribute Pharmaceuticalsthe Vendor, nor is there any certification of any such union with regard to a bargaining unitunit nor has there been any attempt or threat to appeal, re-consider, set aside or vary the order of the Ontario Labour Relations Board dated May 18, 2011 in respect to the application made against inter alia the Corporation by United Food and Commercial Workers Canada, Local 175. There are no grievances against Tribute Pharma or Tribute Pharmaceuticals the Vendor for which Tribute Pharma or Tribute Pharmaceuticals the Vendor has received written notice under any collective agreement. (c) Schedule 3.1(383.1(30) contains a complete and accurate list of the names employees of all individuals who are employees the Vendor, specifying for each employee, position, salary or consultants of Tribute Pharma or Tribute Pharmaceuticals specifying the wage rate (both current and as proposed to be effective as August 1, 2015), benefits, length of service, titleage, rate of salary and commission or bonus structure for each such employee. structure(s) and whether active at work or not. (d) No notice has been received by Tribute Pharma or Tribute Pharmaceuticals the Vendor pertaining to the Business of any complaint filed by any of the employees against Tribute Pharma or Tribute Pharmaceuticals the Vendor claiming that Tribute Pharma or Tribute Pharmaceuticals the Vendor has violated any Laws applicable to employee or human rights, or of any complaints or proceedings of any kind involving Tribute Pharma or Tribute Pharmaceuticals the Vendor or any of the employees of Tribute Pharma or Tribute Pharmaceuticals the Vendor before any labour relations board, except as disclosed in Schedule 3.1(38). All levies, assessments and penalties made against Tribute Pharma or Tribute Pharmaceuticals the Vendor pursuant to any Laws applicable to workers’ compensation have been paid by Tribute Pharma or Tribute Pharmaceuticals and neither of Tribute Pharma or Tribute Pharmaceuticals has been assessed under any such legislation during the past two yearsVendor. (de) All accruals for unpaid vacation pay, premiums for employment insurance, health premiums, Canada Pension Plan premiums, accrued wages, salaries and commissions and employee benefit plan payments have been reflected in the Records. (f) As relates to the Business, there are no notices of assessment, provisional assessment, reassessment, supplementary assessment, penalty assessment or increased assessment or, to the best knowledge of the Vendor, there is no matter or state of facts which could give rise to any such assessment or increase in liability (collectively, “Assessments”) or any other outstanding communications related thereto which the Vendor has received from any workers’ compensation or workplace safety and insurance board or similar authorities in Canada, and, as relates to the Business, there are no Assessments which are unpaid on the date hereof. The Vendor’s accident cost experience relating to the Business is such that there are no pending or possible assessments and there are no claims or potential claims which may adversely affect the Vendor’s accident cost experience.

Labour and Employee Matters. (a) Schedule 3.1(383.1(36) identifies each retirement, pension, bonus, stock purchase, profit sharing, stock option, deferred compensation, pension or supplemental pension, severance or termination pay, life or other insurance, medical, hospital, dental, vision care, drug, sick leave, disability, salary continuation, legal benefits, unemployment benefits, retirement compensation, group registered retirement savings, vacation, incentive or any other compensation plan or arrangement arrangement, whether funded or unfunded, formal or informal, or other employee benefit plan that is maintained or otherwise contributed to, or required to be contributed to, by Tribute Pharma or Tribute Pharmaceuticals the Company for the benefit of employees or former employees of Tribute Pharma or Tribute Pharmaceuticals the Company (the “Employee Plans”) and a true and complete copy of each Employee Plan (as amended to date) has been furnished to the Purchaser, together with a true, accurate and complete copies of all documents relating to each Employee Plan. Each Employee Plan has been maintained in compliance with its terms and with the material requirements prescribed by any and all Laws that are applicable to such Employee Plan. The Vendors have delivered to the Purchaser the actuarial valuations, if any, prepared for each Employee Plan during the past three years. Except as described in Schedule 3.1(383.1(36): (i) all contributions to and payments from each Employee Plan that may have been required to be made in accordance with the terms of any such Employee Plan, or with the recommendation of the actuary for such Employee Plan, and, where applicable, with the Laws that govern such Employee Plan, have been made in a timely mannermanner and no taxes, interest, penalties or fees are owing or exigible under any of the Employee Plans; (ii) all material reports, returns and similar documents (including applications for approval of contributions) with respect to any Employee Plan required to be filed with any Regulatory Authority or distributed to any Employee Plan participant have been duly filed on a timely basis or distributed; (iii) there are no pending investigations by any Regulatory Authority involving or relating to an Employee Plan, threatened or pending claims (except for claims for benefits payable in the normal operation of the Employee Plans), suits or proceedings against Tribute Pharma or Tribute Pharmaceuticals the Company in respect of any Employee Plan or assertions of any rights or claims to benefits under any Employee Plan that could give rise to a liability nor are there any facts that could give rise to any liability in the event of such investigation, claim, suit or proceeding; (iv) no notice has been received by Tribute Pharma or Tribute Pharmaceuticals the Company of any complaints or other proceedings of any kind involving Tribute Pharma or Tribute Pharmaceuticals the Company or any of the employees of Tribute Pharma or Tribute Pharmaceuticals the Company before any pension board or committee relating to any Employee Plan or to Tribute Pharma or Tribute Pharmaceuticalsthe Company; and (v) the assets of each Employee Plan are at least equal to the liabilities of such Employee Plans based on the actuarial assumptions utilized in the most recent valuation performed by the actuary for such Employee Plan, and neither the Purchaser nor any of its associates or affiliates (other than Tribute Pharma and Tribute Pharmaceuticalsthe Company) will incur any liability with respect to any Employee Plan as a result of the Transactions. (b) Except as described in Schedule 3.1(383.1(36), neither of Tribute Pharma or Tribute Pharmaceuticals the Company has not made any Contract with any labour union or employee association nor made commitments to or conducted negotiations with any labour union or employee association with respect to any future agreements and, except as set out in Schedule 3.1(383.1(36), there are no current attempts to organize or establish any labour union or employee association with respect to any employees of Tribute Pharma or Tribute Pharmaceuticalsthe Company, nor is there any certification of any such union with regard to a bargaining unit. There are no grievances against Tribute Pharma or Tribute Pharmaceuticals the Company for which Tribute Pharma or Tribute Pharmaceuticals the Company has received written notice under any collective agreement. (c) Schedule 3.1(383.1(36) contains a complete and accurate list of all the names of all individuals who are employees of the Company specifying: (i) with respect to the unionized employees, if any, or consultants any non-salaried employees, the rate of Tribute Pharma hourly pay, whether or Tribute Pharmaceuticals specifying not such employee is absent for any reason such as lay-off, leave of absence or workers’ compensation; and (ii) with respect to salaried employees, the length of service, age, title, rate of salary and commission or bonus structure for each such employee. No notice has been received by Tribute Pharma the Company or Tribute Pharmaceuticals of any complaint filed by any of the employees or any Regulatory agency against Tribute Pharma or Tribute Pharmaceuticals the Company claiming that Tribute Pharma or Tribute Pharmaceuticals the Company has violated any Laws applicable to employee or human rights, or of any complaints or proceedings of any kind involving Tribute Pharma or Tribute Pharmaceuticals the Company or any of the employees of Tribute Pharma or Tribute Pharmaceuticals the Company before any labour relations board, except as disclosed in Schedule 3.1(383.1(36). All levies, assessments and penalties made against Tribute Pharma or Tribute Pharmaceuticals the Company pursuant to any Laws applicable to workers’ compensation have been paid by Tribute Pharma or Tribute Pharmaceuticals the Company and neither of Tribute Pharma or Tribute Pharmaceuticals the Company has not been assessed under any such legislation during the past two three (3) years. There are no outstanding orders or charges against the Company under any applicable health and safety legislation. There are no outstanding decisions or settlements or pending settlements under applicable employment standards legislation, including re-instalment rights, which place any obligation on the Company to do or refrain from doing any act. (d) All accruals for unpaid vacation pay, premiums for employment insurance, health premiums, Canada and Quebec Pension Plan premiums, accrued wages, salaries and commissions and employee benefit plan payments have been reflected in the Records.

Labour and Employee Matters. (a) Schedule 3.1(38) T of the Disclosure Statement identifies each retirement, pension, bonus, stock purchase, profit sharing, stock option, deferred compensation, severance or termination pay, insurance, medical, hospital, dental, vision care, drug, sick leave, disability, salary continuation, legal benefits, unemployment benefits, vacation, incentive or other compensation plan or arrangement or other employee benefit plan that is maintained or otherwise contributed to, or required to be contributed to, by Tribute Pharma the Vendor relating to the Business or Tribute Pharmaceuticals the Purchased Assets for the benefit of employees or former employees of Tribute Pharma or Tribute Pharmaceuticals the Vendor (the “Employee Plans”) and a true and complete copy of each Employee Plan has been furnished to the Purchaser. Each To the knowledge of Vendor, each Employee Plan has been maintained in compliance with its terms and with the material requirements prescribed by any and all Laws that are applicable to such Employee Plan. The Vendors have Vendor has delivered to the Purchaser the actuarial valuations, if any, prepared for each Employee Plan during the past three two years. Except as described in Schedule 3.1(38):T of the Disclosure Statement: (i) to the knowledge of Vendor, all contributions to and payments from each Employee Plan that may have been required to be made in accordance with the terms of any such Employee Plan, or with the recommendation of the actuary for such Employee Plan, and, where applicable, with the Laws that govern such Employee Plan, have been made in a timely manner; (ii) to the knowledge of Vendor, all material reports, returns and similar documents (including applications for approval of contributions) with respect to any Employee Plan required to be filed with any Regulatory Authority or distributed to any Employee Plan participant have been duly filed on a timely basis or distributed; (iii) to the knowledge of Vendor, there are no pending investigations by any Regulatory Authority involving or relating to an Employee Plan, threatened or pending claims (except for claims for benefits payable in the normal operation of the Employee Plans), suits or proceedings against Tribute Pharma or Tribute Pharmaceuticals the Vendor in respect of any Employee Plan or assertions of any rights or claims to benefits under any Employee Plan that could give rise to a liability nor are there any facts that could give rise to any liability in the event of such investigation, claim, suit or proceeding; (iv) no notice has been received by Tribute Pharma or Tribute Pharmaceuticals the Vendor of any complaints or other proceedings of any kind involving Tribute Pharma or Tribute Pharmaceuticals the Vendor or any of the employees of Tribute Pharma or Tribute Pharmaceuticals the Vendor before any pension board or committee relating to any Employee Plan or to Tribute Pharma or Tribute Pharmaceuticalsthe Vendor; and (v) the assets of each Employee Plan are at least equal to the liabilities of such Employee Plans based on the actuarial assumptions utilized in the most recent valuation performed by the actuary for such Employee Plan, and neither the Purchaser nor any of its associates or affiliates (other than Tribute Pharma and Tribute Pharmaceuticals) will incur any liability with respect to any Employee Plan as a result of the Transactions. (b) Except as described in Schedule 3.1(38)T of the Disclosure Statement, neither of Tribute Pharma or Tribute Pharmaceuticals the Vendor has not made any Contract with any labour union or employee association nor made commitments to or conducted negotiations with any labour union or employee association with respect to any future agreements and, except as set out in Schedule 3.1(38)T of the Disclosure Statement, to the knowledge of Vendor, there are no current attempts to organize or establish any labour union or employee association with respect to any employees of Tribute Pharma or Tribute Pharmaceuticalsthe Vendor, nor is there any certification of any such union with regard to a bargaining unit. There are no grievances against Tribute Pharma or Tribute Pharmaceuticals the Vendor for which Tribute Pharma or Tribute Pharmaceuticals the Vendor has received written notice under any collective agreement. (c) Schedule 3.1(38) T of the Disclosure Statement contains a complete and accurate list of the names of all individuals who are employees of the Vendor specifying: (i) with respect to the unionized employees, the rate of hourly pay, whether or consultants not such employee is absent for any reason such as lay-off, leave of Tribute Pharma absence or Tribute Pharmaceuticals specifying workers’ compensation; and (ii) with respect to salaried employees, the length of service, age, title, rate of salary and commission or bonus structure for each such employee. . (d) No notice has been received by Tribute Pharma or Tribute Pharmaceuticals the Vendor of any complaint filed by any of the employees against Tribute Pharma or Tribute Pharmaceuticals the Vendor claiming that Tribute Pharma or Tribute Pharmaceuticals the Vendor has violated any Laws applicable to employee or human rights, or of any complaints or proceedings of any kind involving Tribute Pharma or Tribute Pharmaceuticals the Vendor or any of the employees of Tribute Pharma or Tribute Pharmaceuticals the Vendor before any labour relations board, except as disclosed in Schedule 3.1(38)T of the Disclosure Statement. All levies, assessments and penalties made against Tribute Pharma or Tribute Pharmaceuticals the Vendor pursuant to any Laws applicable to workers’ compensation have been paid by Tribute Pharma or Tribute Pharmaceuticals the Vendor and neither of Tribute Pharma or Tribute Pharmaceuticals the Vendor has not been assessed under any such legislation during the past two yearssince inception. (de) All To the knowledge of Vendor, all accruals for unpaid vacation pay, premiums for employment insurance, health premiums, Canada Pension Plan pension plan premiums, accrued wages, salaries and commissions and employee benefit plan payments have been reflected in the Records.